IRWD icon

Ironwood Pharmaceuticals

239 hedge funds and large institutions have $2.02B invested in Ironwood Pharmaceuticals in 2022 Q2 according to their latest regulatory filings, with 56 funds opening new positions, 76 increasing their positions, 78 reducing their positions, and 31 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more first-time investments, than exits

New positions opened: | Existing positions closed:

more ownership

Funds ownership:

more funds holding

Funds holding:

3% less repeat investments, than reductions

Existing positions increased: 76 | Existing positions reduced: 78

3% less capital invested

Capital invested by funds: $2.09B → $2.02B (-$72.4M)

50% less funds holding in top 10

Funds holding in top 10: 21 (-1)

Holders
239
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$876K
Puts
$231K
Net Calls
Net Calls Change

Top Buyers

1 +$142M
2 +$31.9M
3 +$29.9M
4
Renaissance Technologies
Renaissance Technologies
New York
+$26.4M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$13M

Top Sellers

1 -$71.7M
2 -$29.8M
3 -$18.7M
4
Norges Bank
Norges Bank
Norway
-$18.6M
5
Citadel Advisors
Citadel Advisors
Florida
-$10.5M
Name Holding Trade Value Shares
Change
Change in
Stake
126
$538K
127
$527K
128
$518K
129
$518K
130
$511K
131
$508K
132
$504K
133
$473K
134
$448K
135
$447K
136
$435K
137
$431K
138
$430K
139
$427K
140
$401K
141
$400K
142
$390K
143
$384K
144
$367K
145
$367K
146
$365K
147
$363K
148
$347K
149
$334K
150
$329K